https://clinicaltrials.gov/ct2/show/NCT03597022?type=Intr&cond=hemophilia&lupd_s=02%2F26%2F2019&lupd_d=14
Condition : Hemophilia A and B
Intervention : Drug: BAY1093884
Sponsor : Bayer
Recruiting
Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors
NCT03597022
Tue, 24 Jul 2018 12:00:00 EDT
Last Update Posted: 03/12/19 09:58AM
